Clinical and Genomic Landscape of FGFR3 Alterations Across Different Stages of Urothelial Cancer

膀胱癌 医学 成纤维细胞生长因子受体3 肿瘤科 内科学 阶段(地层学) 人口 回顾性队列研究 癌症 病理 受体 成纤维细胞生长因子 生物 环境卫生 古生物学
作者
Maximilian Haas,Roman Mayr,Danijel Sikic,Bernd Wullich,Niklas Klümper,Philipp Erben,Ralph Markus Wirtz,Christian Bolenz,Florian Roghmann,Robert Stöhr,Veronika Bahlinger,Arndt Hartmann,Maximilian Burger,Johannes Breyer,Markus Eckstein
出处
期刊:European urology open science [Elsevier BV]
卷期号:77: 1-9 被引量:13
标识
DOI:10.1016/j.euros.2025.04.005
摘要

Background and objective Our aim was to provide a comprehensive analysis of the prevalence of potentially targetable activating FGFR3 alterations and their impact on oncological outcomes across different urothelial carcinoma (UC) stages. Methods We retrospectively analyzed clinical data and FGFR3 results for 1509 formalin-fixed, paraffin-embedded tissue specimens. Actionable activating FGFR3 mutations were assessed using a well-established multiplex SNaPshot polymerase chain reaction approach. FGFR3 fusion testing was performed with a Qiagen Therascreen kit. Key findings and limitations In the study population of 1509 patients, 202 (13%) had stage pTa, 380 (25%) had stage pT1, 258 (17%) had localized muscle-invasive bladder cancer (MIBC), 556 (37%) had locally advanced MIBC, 91 (6.0%) had metastatic UC of the bladder (mUCB), and 22 (1.5%) had metastatic upper tract UC (mUTUC). Of the FGFR3 alterations detected in 373 patients (25%), 104 (52%) were in stage pTa, 158 (42%) were in pT1, 42 (16%) were in localized MIBC, 53 (9.5%) were in locally advanced MIBC, nine (9.9%) were in mUCB, and seven (32%) were in mUTUC. FGFR3 alterations were associated with better progression-free survival and overall survival in the overall population ( p < 0.001), but not in subgroup analyses for different disease stages. Study limitations include the retrospective design and heterogeneous patient cohort. Conclusions and clinical implications FGFR3 alterations occur at a stage-dependent frequency and are more prevalent in lower tumor stages. We were unable to demonstrate an independent prognostic effect of FGFR3 alterations on oncological outcomes after adjusting for tumor stage. Patient summary We analyzed a protein called fibroblast growth factor receptor 3 (FGFR3) in patients with cancer of the urinary tract. We found that more aggressive tumors had fewer genetic changes in FGFR3 in comparison to less aggressive tumors. However, genetic changes in FGFR3 were not related to survival for these patients.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
didi发布了新的文献求助30
1秒前
feifei发布了新的文献求助10
1秒前
yy发布了新的文献求助10
2秒前
orixero的应助被Kiki采纳,获得10
2秒前
凉白开完成签到,获得积分10
2秒前
2秒前
汉堡包的应助被小瑶采纳,获得10
2秒前
2秒前
思源的应助被秦志文采纳,获得10
3秒前
3秒前
蓝天发布了新的文献求助200
3秒前
wuliweiwei完成签到,获得积分10
4秒前
5秒前
陈雅茹发布了新的文献求助10
5秒前
希望天下0贩的0的应助被墨白采纳,获得10
5秒前
Hello的应助被科研通管家采纳,获得10
5秒前
完美世界的应助被科研通管家采纳,获得10
5秒前
NexusExplorer的应助被科研通管家采纳,获得10
5秒前
C.Cat的应助被科研通管家采纳,获得10
6秒前
桐桐的应助被科研通管家采纳,获得10
6秒前
爆米花的应助被科研通管家采纳,获得10
6秒前
6秒前
CipherSage的应助被科研通管家采纳,获得10
6秒前
小杨梅发布了新的文献求助10
6秒前
6秒前
情怀的应助被科研通管家采纳,获得10
6秒前
NexusExplorer的应助被科研通管家采纳,获得10
6秒前
SciGPT的应助被科研通管家采纳,获得10
6秒前
C.Cat的应助被科研通管家采纳,获得10
7秒前
YYM完成签到 ,获得积分10
7秒前
7秒前
十三月发布了新的文献求助10
8秒前
cherry完成签到,获得积分10
8秒前
int0发布了新的文献求助10
8秒前
nansang发布了新的文献求助10
8秒前
满栀完成签到,获得积分20
9秒前
英俊的铭的应助被吃饭饭采纳,获得10
9秒前
深情安青的应助被yy采纳,获得10
9秒前
qqq完成签到,获得积分10
10秒前
zzz完成签到 ,获得积分10
10秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology)求助 1000
Encyclopedia of Modern Artificial Intelligence 1000
John McDowells Bildungstheorie 800
Analyses de reconnaissances de dettes passées devant les échevins d'Ypres (1249-1291) 600
Synthesis, Application and Future Perspectives of Smart Nano-materials - Part 1 400
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8153492
求助须知:如何正确求助?哪些是违规求助? 9550166
关于积分的说明 21696892
捐赠科研通 7742051
什么是DOI,文献DOI怎么找? 3425502
关于科研通互助平台的介绍 2550620
邀请新用户注册赠送积分活动 2469156